immunology

Existing COVID-19 vaccines are unlikely to be effective against Omicron COVID-19 variant: Moderna’s CEO Stéphane Bancel

By admin1 on November 30, 2021 • ( 0 )

In a significant development, Moderna’s CEO Stéphane Bancel said, it is unlikely that existing COVID-19 vaccines will be effective against the Omicron COVID-19 variant. With Bancel’s comments reaching the market, crude oil futures shed more than a dollar, the Nikkei gave… Read More ›

Bristol-Myers Squibb Co and Eisai Co to jointly develop, market experimental cancer drug

By admin1 on June 18, 2021 • ( 0 )

In a statement, Bristol-Myers Squibb Co and Eisai Co said, they had entered into an agreement to jointly develop and market an experimental cancer drug worth up to $3.10 billion. Bristol-Myers would pay $650 million, including for research and development… Read More ›